YungShin Global Holding Corporation (TPE:3705)

Market Cap	15.02B
Revenue (ttm)	8.37B
Net Income (ttm)	963.10M
Shares Out	266.36M
EPS (ttm)	3.62
PE Ratio	15.60
Forward PE	n/a
Dividend	3.00 (5.26%)
Ex-Dividend Date	Jun 24, 2025

Volume	192,459
Average Volume	247,421
Open	57.20
Previous Close	57.00
Day's Range	56.40 - 57.20
52-Week Range	51.90 - 69.90
Beta	0.06
RSI	50.64
Earnings Date	Nov 11, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2024, YungShin Global Holding's revenue was 8.03 billion, an increase of 14.29% compared to the previous year's 7.03 billion. Earnings were 1.17 billion, an increase of 41.24%.